Trial Outcomes & Findings for Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection (CRP-Track) (NCT NCT02395380)
NCT ID: NCT02395380
Last Updated: 2026-04-20
Results Overview
Comparison C-reactive protein levels \< 172 mg/l at 3 post operative day with composite endpoint postoperative recovery (fever, absence of pain \>2, intestinal gas transit and patient autonomy for mobility and body care) at 5 post operative day. The Specificity, Sensitivity, PPV, NPV of C-Reactive Protein Levels at Day 3 Post-operative in Determining Day 5 Post-operative Recovery
COMPLETED
NA
174 participants
5 postoperative days
2026-04-20
Participant Flow
Of 174 enrolled participants, 168 met inclusion criteria
Participant milestones
| Measure |
C-reactive Protein Dosage
C-reactive protein dosage
|
|---|---|
|
Overall Study
STARTED
|
174
|
|
Overall Study
COMPLETED
|
168
|
|
Overall Study
NOT COMPLETED
|
6
|
Reasons for withdrawal
| Measure |
C-reactive Protein Dosage
C-reactive protein dosage
|
|---|---|
|
Overall Study
CRP measuring missing
|
5
|
|
Overall Study
Unscheduled stoma
|
1
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
C-reactive Protein Dosage
n=168 Participants
C-reactive protein dosage
|
|---|---|
|
Age, Continuous
|
65.1 years
STANDARD_DEVIATION 13.2 • n=168 Participants
|
|
Sex: Female, Male
Female
|
76 Participants
n=168 Participants
|
|
Sex: Female, Male
Male
|
92 Participants
n=168 Participants
|
PRIMARY outcome
Timeframe: 5 postoperative daysPopulation: C-reactive Protein \< 172 mg/l overall postoperative recovery within 5 days.
Comparison C-reactive protein levels \< 172 mg/l at 3 post operative day with composite endpoint postoperative recovery (fever, absence of pain \>2, intestinal gas transit and patient autonomy for mobility and body care) at 5 post operative day. The Specificity, Sensitivity, PPV, NPV of C-Reactive Protein Levels at Day 3 Post-operative in Determining Day 5 Post-operative Recovery
Outcome measures
| Measure |
C-reactive Protein Dosage
n=168 Participants
C-reactive protein dosage
|
|---|---|
|
C-reactive Protein Rate
Sensitivity
|
47.9 percentage
Interval 33.8 to 62.0
|
|
C-reactive Protein Rate
Specificity
|
81.0 percentage
Interval 74.0 to 88.0
|
|
C-reactive Protein Rate
PPV
|
50.0 percentage
Interval 35.5 to 64.4
|
|
C-reactive Protein Rate
NPV
|
79.5 percentage
Interval 72.6 to 86.8
|
Adverse Events
C-reactive Protein Dosage
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place